Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction
BACKGROUND: The role of angiotensin-converting enzyme (ACE) inhibitors in patients with
heart failure and preserved ejection fraction remains unclear. METHODS: Of the 10,570 …
heart failure and preserved ejection fraction remains unclear. METHODS: Of the 10,570 …
Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995
NL Smith, BM Psaty, B Pitt, R Garg… - Archives of Internal …, 1998 - jamanetwork.com
Background Evidence from clinical trials in the past decade has consistently shown that
angiotensin-converting enzyme (ACE) inhibitors reduce morbidity and mortality in patients …
angiotensin-converting enzyme (ACE) inhibitors reduce morbidity and mortality in patients …
Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community setting
EF Philbin - Clinical cardiology, 1998 - Wiley Online Library
Background: Angiotensin‐converting enzyme (ACE) inhibitors were underprescribed for
patients with congestive heart failure (CHF) treated in the community setting in the early …
patients with congestive heart failure (CHF) treated in the community setting in the early …
A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients …
Y Zhang, GC Fonarow, PW Sanders… - The American journal of …, 2011 - Elsevier
The comparative effectiveness of angiotensin-converting enzyme (ACE) inhibitors versus
angiotensin II type 1 receptor blockers (ARBs) in real-world older heart failure (HF) patients …
angiotensin II type 1 receptor blockers (ARBs) in real-world older heart failure (HF) patients …
Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior
A Ferreira, P Bettencourt, M Cortez, JP Araujo… - Journal of Cardiac …, 1997 - Elsevier
Background: Several studies document an underuse of angiotensin-converting enzyme
inhibitors (ACEIs) in heart failure (HF) patients, despite their proven efficacy and good …
inhibitors (ACEIs) in heart failure (HF) patients, despite their proven efficacy and good …
Evaluating the use of angiotensin‐converting enzyme inhibitors for older nursing home residents with chronic heart failure
DE Forman, RB Cbander, KL Lapane… - Journal of the …, 1998 - Wiley Online Library
BACKGROUND: Despite their well noted therapeutic benefits for heart failure (HF),
angiotensin‐converting enzyme (ACE) inhibitors may be underprescribed and underdosed …
angiotensin‐converting enzyme (ACE) inhibitors may be underprescribed and underdosed …
Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved …
LG Shamagian, AV Roman, PM Ramos… - Journal of cardiac …, 2006 - Elsevier
BACKGROUND: The use of inhibitors of angiotensin-converting enzyme (ACE) is strongly
indicated by a diagnosis of congestive heart failure (CHF) with deteriorated systolic function …
indicated by a diagnosis of congestive heart failure (CHF) with deteriorated systolic function …
Patterns of ACE inhibitor use in elderly Medicaid patients with heart failure
PA Howard, TI Shireman, A Dhingra… - … American journal of …, 2002 - Wiley Online Library
The authors identified 321 elderly Kansas Medicaid patients with congestive heart failure
and examined angiotensin‐converting enzyme (ACE) inhibitor use. Using retrospective …
and examined angiotensin‐converting enzyme (ACE) inhibitor use. Using retrospective …
Patterns of angiotensin‐converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure
MM Mcdermott, P Lee, S Mehta… - Clinical …, 1998 - Wiley Online Library
Background: Among hospitalized patients with heart failure, we describe characteristics
associated with prescription of angiotensin‐converting enzyme (ACE) inhibitors in the doses …
associated with prescription of angiotensin‐converting enzyme (ACE) inhibitors in the doses …
Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study
M Echemann, F Zannad, S Briancon, Y Juilliere… - American Heart …, 2000 - Elsevier
Background Angiotensin-converting enzyme (ACE) inhibitors have been demonstrated to
reduce morbidity and mortality rates in patients with heart failure with left ventricular systolic …
reduce morbidity and mortality rates in patients with heart failure with left ventricular systolic …